Treatment previously received emergency use authorization by the FDA.
Novavax, Inc. revealed that it has finalized agreements with major pharmacy retailers in the US to provide its new COVID-19 vaccine. adjuvanted (NVX-CoV2601) for individuals aged 12 and up. Companies that carry the vaccine include Costco, CVS Pharmacy, Giant, Publix, Rite Aid, Stop & Shop, and Topco, a large retail purchaser for member pharmacies. This comes after the vaccine received emergency use authorization (EUA) from the FDA earlier this month.
"We are committed to ensuring immediate nationwide availability of our protein-based non-mRNA vaccine, and our agreements with leading U.S. pharmacy retailers will ensure people have options to help protect themselves and their loved ones against COVID-19 this fall," said John C. Jacobs, president, CEO, Novavax. "Individuals will have access to our protein-based vaccine through major pharmacies, clinics, physicians' offices and government programs."
Reference: Novavax COVID-19 Vaccine Doses Available at Major Retail Pharmacies Across the US. PR Newswire. October 13, 2023. Accessed October 13, 2023. https://www.prnewswire.com/news-releases/novavax-covid-19-vaccine-doses-available-at-major-retail-pharmacies-across-the-us-301956198.html
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.